Table 2.

Predictors of mortality among COVID-19 patients.

	Survivors (n = 370)	Non-survivors (n = 16)	P value
Categorical variables
Gender
Male	222 (60.0%)	11 (68.8%)	0.336
Female	148 (40.0%)	5 (31.2%)
Diabetes mellitus
Yes	61 (16.5%)	6 (37.5%)	0.042
No	309 (83.5%)	10 (62.5%)
Hypertension
Yes	79 (21.4%)	7 (43.8%)	0.042
No	291 (78.6%)	9 (56.2%)
Coronary artery disease
Yes	24 (6.5%)	2 (12.5%)	0.294
No	346 (93.5%)	14 (87.5%)
Acute kidney injury
Yes	9 (2.4%)	12 (75.0%)	<0.0001
No	361 (97.6%)	4 (25.0%)
New-onset hyperglycemia
Yes	27 (8.7%)	6 (60%)	<0.0001
No	282 (91.3%)	4 (40%)
On oxygen/ventilator
Yes	67 (18.1%)	15 (93.8%)	<0.0001
No	303 (81.9%)	1 (6.2%)
Continuous variables
Age (years)	48.1 ± 16.3	63.4 ± 14.0	<0.0001
Duration of stay (days)	9.6 ± 3.8	15.8 ± 7.6	<0.0001
Hemoglobin (g%)	13.1 ± 1.9	12.2 ± 2.5	0.171
Total leukocyte count (/µL)	7562 ± 8192	9233 ± 4162	0.045
Neutrophil count (/µL)	4611 ± 4345	7790 ± 4298	0.001
Lymphocyte count (/µL)	2432 ± 7671	930 ± 532	<0.0001
Platelet count (×103)	251 ± 94	206 ± 54	0.040
Urea (mg/dL)	22.8 ± 10.5	52.7 ± 42.1	0.008
Creatinine (mg/dL)	1.1 ± 0.9	1.5 ± 1.0	<0.0001
AST (U/L)	32 ± 28	64 ± 41	0.001
ALT (U/L)	35 ± 53	49 ± 37	0.022
Total bilirubin (mg/dL)	0.51 ± 0.53	0.75 ± 0.45	0.061
Random plasma glucose (mg/dL)	130.7 ± 72.9	297.0 ± 116.6	<0.0001
D-dimer (µg/mL)	1.3 ± 3.9	5.7 ± 7.2	<0.0001
Lactic dehydrogenase (U/L)	237 ± 93	446 ± 160	<0.0001
Inteleukin 6 (pg/mL)	221 ± 530	441 ± 986	0.026
hsCRP (mg/dL)	21 ± 47	110 ± 66	<0.0001

ALT, alanine aminotransferase; AST, aspartate aminotransferase; hsCRP, highly sensitive C-reactive protein.